Actinium Partners With MSK to Expand Breakthrough AML Therapy Program
NEW YORK, March 20, 2025 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in...
therapy
Actinium Pharmaceuticals Announces Research Collaboration with Memorial Sloan Kettering to Support Further Clinical Expansion of Actimab-A’s Backbone Therapy Strategy
NEW YORK, March 20, 2025 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in...
Queen’s researchers lead $5M national initiative to advance psychedelic therapy in cancer care. | Faculty of Health Sciences
With $5 million in funding from the Canadian Cancer Society and Brain Canada, the national research collaboration will conduct clinical...
